Functional β-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes

Cardiovascular Research

Volumn 71, Issue 1, 2006, Pages 69-78

  Boivin, Benoit ^a,b   Lavoie, Catherine ^a   Vaniotis, George ^a,b   Baragli, Alessandra ^c   Villeneuve, Louis Robert ^a   Ethier, Nathalie ^c   Trieu, Phan ^c   Allen, Bruce G ^a,b   Hébert, Terence E ^b,c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Adrenergic receptors; Cardiac function; G proteins; Nuclear GPCRs; Signalling

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYANOPINDOLOL I 125; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; PERTUSSIS TOXIN; PROCATEROL; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; XAMOTEROL;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL NUCLEUS MEMBRANE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE CELL; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; RAT; RNA SYNTHESIS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

ADENYLATE CYCLASE; ADRENERGIC BETA-3 RECEPTOR AGONISTS; ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOTTING, WESTERN; DIOXOLES; ETHANOLAMINES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HEART VENTRICLES; IMIDAZOLES; IODOCYANOPINDOLOL; ISOPROTERENOL; MICE; MICROSCOPY, CONFOCAL; MYOCYTES, CARDIAC; NUCLEAR ENVELOPE; PERTUSSIS TOXIN; PROPANOLAMINES; RATS; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; SIGNAL TRANSDUCTION;

EID: 33744909351     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.03.015     Document Type: Article

References (61)

1. Gobeil Jr. F., Bernier S.G., Vazquez-Tello A., Brault S., Beauchamp M.H., Quiniou C., et al. Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1. J Biol Chem 278 (2003) 38875-38883
2. 2+ changes in heterologous cell types and neurons. J Biol Chem 278 (2003) 28210-28219
3. Lee D.K., Lanca A.J., Cheng R., Nguyen T., Ji X.D., Gobeil Jr. F., et al. Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors. J Biol Chem 279 (2004) 7901-7908
4. Marrache A.M., Gobeil Jr. F., Bernier S.G., Stankova J., Rola-Pleszczynski M., Choufani S., et al. Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. J Immunol 169 (2002) 6474-6481
5. Lu D., Yang H., Shaw G., and Raizada M.K. Angiotensin II-induced nuclear targeting of the angiotensin type 1 (AT1) receptor in brain neurons. Endocrinology 139 (1998) 365-375
6. Zhuo J.L., Imig J.D., Hammond T.G., Orengo S., Benes E., and Navar L.G. Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor. Hypertension 39 (2002) 116-121
7. Chen R., Mukhin Y.V., Garnovskaya M.N., Thielen T.E., Iijima Y., Huang C., et al. A functional angiotensin II receptor-GFP fusion protein: evidence for agonist-dependent nuclear translocation. Am J Physiol Renal Physiol 279 (2000) F440-F448
8. Gobeil Jr. F., Dumont I., Marrache A.M., Vazquez-Tello A., Bernier S.G., Abran D., et al. Regulation of eNOS expression in brain endothelial cells by perinuclear EP(3) receptors. Circ Res 90 (2002) 682-689
9. Boivin B., Chevalier D., Villeneuve L.R., Rousseau E., and Allen B.G. Functional endothelin receptors are present on nuclei in cardiac ventricular myocytes. J Biol Chem 278 (2003) 29153-29163
10. Zhang J.H., Barr V.A., Mo Y., Rojkova A.M., Liu S., and Simonds W.F. Nuclear localization of G protein β5 and regulator of G protein signaling 7 in neurons and brain. J Biol Chem 276 (2001) 10284-10289
11. Boivin B., Villeneuve L.R., Farhat N., Chevalier D., and Allen B.G. Sub-cellular distribution of endothelin signaling pathway components in ventricular myocytes and heart: lack of preformed caveolar signalosomes. J Mol Cell Cardiol 38 (2005) 665-676
12. Willard F.S., and Crouch M.F. Nuclear and cytoskeletal translocation and localization of heterotrimeric G-proteins. Immunol Cell Biol 78 (2000) 387-394
13. Yamamoto S., Kawamura K., and James T.N. Intracellular distribution of adenylate cyclase in human cardiocytes determined by electron microscopic cytochemistry. Microsc Res Tech 40 (1998) 479-487
14. Schulze W., and Buchwalow I.B. Adenylyl cyclase in the heart: an enzymocytochemical and immunocytochemical approach. Microsc Res Tech 40 (1998) 473-478
15. Schievella A.R., Regier M.K., Smith W.L., and Lin L.L. Calcium-mediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum. J Biol Chem 270 (1995) 30749-30754
16. Kim C.G., Park D., and Rhee S.G. The role of carboxyl-terminal basic amino acids in Gqa-dependent activation, particulate association, and nuclear localization of phospholipase C-β1. J Biol Chem 271 (1996) 21187-21192
17. Freyberg Z., Sweeney D., Siddhanta A., Bourgoin S., Frohman M., and Shields D. Intracellular localization of phospholipase D1 in mammalian cells. Mol Biol Cell 12 (2001) 943-955
18. Burchett S.A. In through the out door: nuclear localization of the regulators of G protein signaling. J Neurochem 87 (2003) 551-559
19. Scott M.G., Le Rouzic E., Perianin A., Pierotti V., Enslen H., Benichou S., et al. Differential nucleocytoplasmic shuttling of β-arrestins. Characterization of a leucine-rich nuclear export signal in β-arrestin2. J Biol Chem 277 (2002) 37693-37701
20. Wang P., Wu Y., Ge X., Ma L., and Pei G. Subcellular localization of β-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus. J Biol Chem 278 (2003) 11648-11653
21. Yi X.P., Gerdes A.M., and Li F. Myocyte redistribution of GRK2 and GRK5 in hypertensive, heart-failure-prone rats. Hypertension 39 (2002) 1058-1063
22. Yi X.P., Zhou J., Baker J., Wang X., Gerdes A.M., and Li F. Myocardial expression and redistribution of GRKs in hypertensive hypertrophy and failure. Anat Rec A Discov Mol Cell Evol Biol 282 (2005) 13-23
23. Johnson L.R., Scott M.G., and Pitcher J.A. G protein-coupled receptor kinase 5 contains a DNA-binding nuclear localization sequence. Mol Cell Biol 24 (2004) 10169-10179
24. Sastri M., Barraclough D.M., Carmichael P.T., and Taylor S.S. A-kinase-interacting protein localizes protein kinase A in the nucleus. Proc Natl Acad Sci U S A 102 (2005) 349-354
25. Xiao R.P., Zhu W., Zheng M., Chakir K., Bond R., Lakatta E.G., et al. Subtype-specific β-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci 25 (2004) 358-365
26. Steinberg S.F., and Brunton L.L. Compartmentation of G protein-coupled signaling pathways in cardiac myocytes. Annu Rev Pharmacol Toxicol 41 (2001) 751-773
27. Steinberg S.F. β(2)-Adrenergic receptor signaling complexes in cardiomyocyte caveolae/lipid rafts. J Mol Cell Cardiol 37 (2004) 407-415
28. Zhu W.Z., Chakir K., Zhang S., Yang D., Lavoie C., Bouvier M., et al. Heterodimerization of β1- and β2-adrenergic receptor subtypes optimizes β-adrenergic modulation of cardiac contractility. Circ Res 9 (20057) 244-251
29. Boivin B., and Allen B.G. Regulation of membrane-bound PKC in adult cardiac ventricular myocytes. Cell Signal 15 (2003) 217-224
30. + current modulates repolarization and excitation-contraction coupling in adult mouse ventricle. J Physiol 504 Pt 3 (1997) 557-563
31. Dawn B., Xuan Y.T., Marian M., Flaherty M.P., Murphree S.S., Smith T.L., et al. Cardiac-specific abrogation of NF-κ B activation in mice by transdominant expression of a mutant IκBα. J Mol Cell Cardiol 33 (2001) 161-173
32. Hebert T.E., Moffett S., Morello J.P., Loisel T.P., Bichet D.G., Barret C., et al. A peptide derived from a β2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 271 (1996) 16384-16392
33. Salomon Y., Londos C., and Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem 58 (1974) 541-548
34. Xu J., Manning F.C., O'Brien T.J., Ceryak S., and Patierno S.R. Mechanisms of chromium-induced suppression of RNA synthesis in cellular and cell-free systems: relationship to RNA polymerase arrest. Mol Cell Biochem 255 (2004) 151-160
35. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
36. Rybin V.O., Xu X., Lisanti M.P., and Steinberg S.F. Differential targeting of β-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem 275 (2000) 41447-41457
37. Steinle J.J., Booz G.W., Meininger C.J., Day J.N., and Granger H.J. β3-adrenergic receptors regulate retinal endothelial cell migration and proliferation. J Biol Chem 278 (2003) 20681-20686
38. Ben-Efraim I., and Gerace L. Gradient of increasing affinity of importin b for nucleoporins along the pathway of nuclear import. J Cell Biol 152 (2001) 411-417
39. Chung C.Y., and Erickson H.P. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J Cell Biol 126 (1994) 539-548
40. Haas I.G. BiP (GRP78), an essential hsp70 resident protein in the endoplasmic reticulum. Experientia 50 (1994) 1012-1020
41. Stroud W.J., Jiang S., Jack G., and Storrie B. Persistence of Golgi matrix distribution exhibits the same dependence on Sar1p activity as a Golgi glycosyltransferase. Traffic 4 (2003) 631-641
42. Herget G.W., Neuburger M., Plagwitz R., and Adler C.P. DNA content, ploidy level and number of nuclei in the human heart after myocardial infarction. Cardiovasc Res 36 (1997) 45-51
43. Kaumann A.J., and Molenaar P. Differences between the third cardiac beta-adrenoceptor and the colonic β3-adrenoceptor in the rat. Br J Pharmacol 118 (1996) 2085-2098
44. Lavoie C., and Hebert T.E. Pharmacological characterization of putative β1-β2-adrenergic receptor heterodimers. Can J Physiol Pharmacol 81 (2003) 186-195
45. Jordan B.A., and Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399 (1999) 697-700
46. Pfeiffer M., Koch T., Schroder H., Klutzny M., Kirscht S., Kreienkamp H.J., et al. Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). J Biol Chem 276 (2001) 14027-14036
47. Lavoie C., Mercier J.F., Salahpour A., Umapathy D., Breit A., Villeneuve L.R., et al. β1/β2-adrenergic receptor heterodimerization regulates β2-adrenergic receptor internalization and ERK signaling efficacy. J Biol Chem 277 (2002) 35402-35410
48. Mercier J.-F., Salahpour A., Angers S., Breit A., and Bouvier M. Quantitative Assessment of β1- and β2-Adrenergic Receptor Homo- and Heterodimerization by Bioluminescence Resonance Energy Transfer. J Biol Chem 277 (2002) 44925-44931
49. Breit A., Lagace M., and Bouvier M. Hetero-oligomerization between β2- and β3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties. J Biol Chem 279 (2004) 28756-28765
50. Rybin V.O., Pak E., Alcott S., and Steinberg S.F. Developmental changes in β2-adrenergic receptor signaling in ventricular myocytes: the role of Gi proteins and caveolae microdomains. Mol Pharmacol 63 (2003) 1338-1348
51. Steinberg S.F. The molecular basis for distinct b-adrenergic receptor subtype actions in cardiomyocytes. Circ Res 85 (1999) 1101-1111
52. Lohse M.J., Engelhardt S., and Eschenhagen T. What is the role of b-adrenergic signaling in heart failure?. Circ Res 93 (2003) 896-906
53. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., and Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307 (2005) 1625-1630
54. Lin S.Y., Makino K., Xia W., Matin A., Wen Y., Kwong K.Y., et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 3 (2001) 802-808
55. Wells A., and Marti U. Signalling shortcuts: cell-surface receptors in the nucleus?. Nat Rev Mol Cell Biol 3 (2002) 697-702
56. Eisenhofer G. The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 91 (2001) 35-62
57. Grundemann D., Schechinger B., Rappold G.A., and Schomig E. Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1 (1998) 349-351
58. Jonker J.W., and Schinkel A.H. Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). J Pharmacol Exp Ther 308 (2004) 2-9
59. Buu N.T., Hui R., and Falardeau P. Norepinephrine in neonatal rat ventricular myocytes: association with the cell nucleus and binding to nuclear α1- and β-adrenergic receptors. J Mol Cell Cardiol 25 (1993) 1037-1046
60. Chidiac P., Hebert T.E., Valiquette M., Dennis M., and Bouvier M. Inverse agonist activity of b-adrenergic antagonists. Mol Pharmacol 45 (1994) 490-499
61. Samama P., Pei G., Costa T., Cotecchia S., and Lefkowitz R.J. Negative antagonists promote an inactive conformation of the β2-adrenergic receptor. Mol Pharmacol 45 (1994) 390-394